Report on the 11- to 13+6-week ultrasound evaluation as a screening test for trisomy 21 in singleton pregnancies

American Journal of Perinatology

Volumn 26, Issue 10, 2009, Pages 703-710

  Borrell, Antoni ^a,b   Robinson, Julian N ^b   Santolaya Forgas, Joaquin ^c  

^a HOSPITAL CLÍNIC   (Spain)

^b NEWTON WELLESLEY HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

3 D ultrasound; Doppler; First trimester prenatal screening; Ultrasound

Indexed keywords

CRANIOFACIAL MALFORMATION; DOPPLER ECHOCARDIOGRAPHY; DUCTUS VENOSUS; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SECOND TRIMESTER PREGNANCY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; TRISOMY 21; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ULTRASOUND;

DOWN SYNDROME; FACE; FEMALE; FETAL HEART; HUMANS; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROGRAM EVALUATION; ULTRASONOGRAPHY, PRENATAL;

EID: 70449433119     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0029-1223281     Document Type: Review

References (86)

1. Szabó J, Gellen J. Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester. Lancet 1990 336 1133
2. Nicolaides K H., Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992 304 867-869
3. Pandya P P., Snijders R J., Johnson S P., De Lourdes Brizot M, Nicolaides K H. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995 102 957-962
4. Snijders R J., Noble P, Sebire N, Souka A, Nicolaides K H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 1014 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998 352 343-346
5. Wapner R, Thom E, Simpson J L. et al, First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003 349 1405-1413
6. Wald N J., Rodeck C, Hackshaw A K., Walters J, Chitty L, Mackinson A M., SURUSS Research Group. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003 7 1-77
7. Malone F D., Canick J A., Ball R H. et al. First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005 353 2001-2011
8. Nicolaides K H. Fetal Medicine Foundation. http://www.studiolift.com/ fetal/site/FMF-English.pdf Last accessed June 12, 2009
9. Abuhamad A. Technical aspects of nuchal translucency measurement. Semin Perinatol 2005 29 376-379
10. Nuchal Translucency Oversight Committee. Nuchal Translucency Quality Review. http://www.ntqr.org/SM/Provider/wfProviderInformation.aspx Last accessed June 12, 2009
11. Evans M I., Van Decruyes H, Nicolaides K H. Nuchal translucency measurements for first-trimester screening: the price of inaccuracy. Fetal Diagn Ther 2007 22 401-404
12. Spencer K, Bindra R, Nix A B., Heath V, Nicolaides K H. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol 2003 22 142-148
13. Gyselaers W J., Vereecken A J., Van Herck E J., Straetmans D P., Ombelet W U., Nijhuis J G. Nuchal translucency thickness measurements for fetal aneuploidy screening: Log NT-MoM or Delta-NT, performer-specific medians and ultrasound training. J Med Screen 2006 13 4-7
14. Wright D, Kagan K O., Molina F S., Gazzoni A, Nicolaides K H. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008 31 376-383
15. Palomaki G E., Neveux L M., Donnenfeld A et al. Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective. Genet Med 2008 10 131-138
16. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolides K H. Absence of nasal bone in fetuses with trisomy 21 at 1114 weeks of gestation: an observational study. Lancet 2001 358 1665-1667
17. Otano L, Aiello H, Igarzbal L, Matayoshi T, Gadow E C. Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome. Prenat Diagn 2002 22 930-932
18. Zoppi M A., Ibba R M., Axiana C, Floris M, Manca F, Monni G. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies. Prenat Diagn 2003 23 496-500
19. Orlandi F, Bilardo C M., Campogrande M et al. Measurement of nasal bone length at 1114 weeks of pregnancy and its potential role in Down syndrome risk assessment. Ultrasound Obstet Gynecol 2003 22 36-39
20. Viora E, Masturzo B, Errante G, Sciarrone A, Bastonero S, Campogrande M. Ultrasound evaluation of fetal nasal bone at 11 to 14 weeks in a consecutive series of 1906 fetuses. Prenat Diagn 2003 23 784-787
21. Senat M V., Bernard J P., Boulvain M, Ville Y. Intra- and interoperator variability in fetal nasal bone assessment at 1114 weeks of gestation. Ultrasound Obstet Gynecol 2003 22 138-141
22. Wong S F., Ng W F., Ho L C. Histopathological findings of the nose of Down syndrome abortuses. Prenat Diagn 2003 23 561-563
23. Cicero S, Rembouskos G, Vandecruys H, Hogg M, Nicolaides K H. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone al the 1114-week scan. Ultrasound Obstet Gynecol 2004 23 218-223
24. Malone F D., Ball R H., Nyberg D A. et al. First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol 2004 104 1222-1228
25. Weingertner A S., Kohler M, Firtion C, Vayssière C, Favre R. Interest of foetal nasal bone measurement at first trimester trisomy 21 screening. Fetal Diagn Ther 2006 21 433-438
26. Kozlowski P, Knippel A J., Froehlich S, Stressig R. Additional performance of nasal bone in first trimester screening. 2006. Ultraschall Med 2006 27 336-339
27. Ramos-Corpas D, Santiago J C., Montoya F. Ultrasonographic evaluation of fetal nasal bone in a low-risk population at 1113+6 gestational weeks. Prenat Diagn 2006 26 112-117
28. Prefumo F, Sairam S, Bhide A, Thilaganathan B. First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations. Am J Obstet Gynecol 2006 194 828-833
29. Sepulveda W, Wong A E., Dezerega V. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone. Obstet Gynecol 2007 109 1040-1045
30. Moon M H., Cho J Y., Lee Y M. et al. First-trimester screening for Down syndrome; the role of nasal bone assessment in the Korean population. Prenat Diagn 2007 27 830-834
31. Borrell A, Borobio V, Gonce A et al. Fetal nasal bone and ductus venosus blood flow assessed transvaginally at the 1114 week scannew data including unselected and high risk pregnancies. OC13. Ultrasound Obstet Gynecol 2006 28 362
32. Ville Y. What is the role of fetal nasal bone examination in the assessment of risk for trisomy 21 in clinical practice? Am J Obstet Gynecol 2006 195 1-3
33. Peralta C FA, Falcon O, Wegrzyn P, Faro C, Nicolaides K H. Assessment of the gap between the fetal nasal bones at 11 to 13+6 weeks of gestation by three-dimensional ultrasound. Ultrasound Obstet Gynecol 2005 25 464-467
34. Benoit B, Chaoui R. Three-dimensional ultrasound with maximal mode rendering: a novel technique for the diagnosis of bilateral or unilateral absence or hypoplasia of nasal bones in second-trimester screening for Down syndrome. Ultrasound Obstet Gynecol 2005 25 19-24
35. Dagklis T, Plasencia W, Maiz N, Duarte L, Nicolaides K H. Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11+0 to 13+6 weeks. Ultrasound Obstet Gynecol 2008 31 132-135
36. Kiserud T, Eik-Nes S H., Blaas H G., Hellevik L R. Ultrasonographic velocimetry of the fetal ductus venosus. Lancet 1991 338 1412-1414
37. Borrell A, Gonce A, Martinez J M. et al. First-trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers. Prenat Diagn 2005 25 901-905
38. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides K H. Screening for chromosomal abnormalities at 1014 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998 12 380-384
39. Borrell A, Antolin E, Costa D, Farre M T., Martinez J M., Fortuny A. Abnormal ductus venosus blood flow in trisomy 21 fetuses during early pregnancy. Am J Obstet Gynecol 1998 179 1612-1617
40. Matias A, Huggon I, Areias J C., Montenegro N, Nicolaides K H. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 1014 weeks. Ultrasound Obstet Gynecol 1999 14 307-310
41. Montenegro N, Matias A, Areias J C., Castedo S, Barros H. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997 10 265-268
42. Borrell A. The ductus venosus in early pregnancy and congenital anomalies. Prenat Diagn 2004 24 688-692
43. Prefumo F, Risso D, Venturini P L., De Biasio P. Reference values for ductus venosus Doppler flow measurements at 1014 weeks of gestation. Ultrasound Obstet Gynecol 2002 20 42-46
44. Bilardo C M., Muller M A., Zikulnig L, Schipper M, Hecher K. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 2001 17 288-294
45. Antolin E, Comas C, Torrents M et al. The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 1016 weeks of gestation. Ultrasound Obstet Gynecol 2001 17 295-300
46. Zoppi M A., Putzolu M, Ibba R M., Floris M, Monni G. First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype. Fetal Diagn Ther 2002 17 52-57
47. Mavrides E, Sairam S, Hollis B, Thilaganathan B. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus. BJOG 2002 109 1015-1019
48. Murta C GV, Moron A F., Avila M AP, Weiner C P. Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy. Fetal Diagn Ther 2002 17 308-314
49. Toyama J M., Brizot M L., Liao A W. et al. Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome. Ultrasound Obstet Gynecol 2004 23 341-345
50. Borrell A, Martinez J M., Seres A, Borobio V, Cararach V, Fortuny A. Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy. Prenat Diagn 2003 23 921-926
51. Prefumo F, De Biasio P, Venturini P L. Reproducibility of ductus venosus Doppler flow measurements at 1114 weeks of gestation. Ultrasound Obstet Gynecol 2001 17 301-305
52. Mavrides E, Holden D, Bland J M., Tekay A, Thilaganathan B. Intraobserver and interobserver variability of transabdominal Doppler velocimetry measurements of the fetal ductus venosus between 10 and 14 weeks of gestation. Ultrasound Obstet Gynecol 2001 17 306-310
53. Borrell A, Perez M, Figueras F, Meler E, Gonce A, Gratacos E. Reliability analysis on ductus venosus assessment at 1114 weeks' gestation in a high-risk population. Prenat Diagn 2007 27 442-446
54. Huggon I C., DeFigueiredo D B., Allan L D. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 1114 weeks of gestation. Heart 2003 89 1071-1073
55. Faiola S, Tsoi E, Huggon I C., Allan L D., Nicolaides K H. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13+6-week scan. Ultrasound Obstet Gynecol 2005 26 22-27
56. Falcon O, Faiola S, Huggon I, Allan L, Nicolaides K H. Fetal tricuspid regurgitation at the 11+0 to 13+6-week scan: association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol 2006 27 609-612
57. Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides K H. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11+0 to 13+6 weeks. Ultrasound Obstet Gynecol 2006 27 151-155
58. McAuliffe F M., Trines J, Nield L E., Chitayat D, Jaeggi E, Hornberger L K. Early fetal echocardiographya reliable prenatal diagnosis tool. Am J Obstet Gynecol 2005 193 (3 Pt 2) 1253-1259
59. Smrcek J M., Krapp M, Axt-Fliedner R et al. Atypical ductus venosus blood flow pattern in fetuses with severe tricuspid valve regurgitation. Ultrasound Obstet Gynecol 2005 26 180-182
60. Messing B, Porat S, Imbar T, Valsky D V., Anteby E Y., Yagel S. Mild tricuspid regurgitation: a benign fetal finding at various stages of pregnancy. Ultrasound Obstet Gynecol 2005 26 606-609 discussion 610
61. Falcon O, Wegrzyn P, Faro C, Peralta C F., Nicolaides K H. Gestational sac volume measured by three-dimensional ultrasound at 11 to 13+6 weeks of gestation: relation to chromosomal defects. Ultrasound Obstet Gynecol 2005 25 546-550 (Pubitemid 40835456)
62. Wegrzyn P, Faro C, Falcon O, Peralta C F., Nicolaides K H. Placental volume measured by three-dimensional ultrasound at 11 to 13+6 weeks of gestation: relation to chromosomal defects. Ultrasound Obstet Gynecol 2005 26 28-32 (Pubitemid 41537008)
63. Falcon O, Cavoretto P, Peralta C F., Csapo B, Nicolaides K H. Fetal head-to-trunk volume ratio in chromosomally abnormal fetuses at 11+0 to 13+6 weeks of gestation. Ultrasound Obstet Gynecol 2005 26 755-760 (Pubitemid 41810138)
64. Falcon O, Peralta C F., Cavoretto P, Auer M, Nicolaides K H. Fetal trunk and head volume in chromosomally abnormal fetuses at 11+0 to 13+6 weeks of gestation. Ultrasound Obstet Gynecol 2005 26 517-520 (Pubitemid 41634538)
65. Falcon O, Peralta C F., Cavoretto P, Faiola S, Nicolaides K H. Fetal trunk and head volume measured by three-dimensional ultrasound at 11+0 to 13+6 weeks of gestation in chromosomally normal pregnancies. Ultrasound Obstet Gynecol 2005 26 263-266
66. Cicero S, Curcio P, Rembouskos G, Sonek J, Nicolaides K H. Maxillary length at 1114 weeks of gestation in fetuses with trisomy 21. Ultrasound Obstet Gynecol 2004 24 19-22 (Pubitemid 38932242)
67. Borenstein M, Persico N, Kaihura C, Sonek J, Nicolaides K H. Frontomaxillary facial angle in chromosomally normal fetuses at 11+0 to 13+6 weeks. Ultrasound Obstet Gynecol 2007 30 737-741 (Pubitemid 47612695)
68. Sonek J, Borenstein M, Dagklis T, Persico N, Nicolaides K H. Frontomaxillary facial angle in fetuses with trisomy 21 at 1113(6) weeks. Am J Obstet Gynecol 2007 196 e1-e4
69. Borenstein M, Persico N, Strobl I, Sonek J, Nicolaides K H. Frontomaxillary and mandibulomaxillary facial angles at 11+0 to 13+6 weeks in fetuses with trisomy 18. Ultrasound Obstet Gynecol 2007 30 928-933
70. Borenstein M, Persico N, Dagklis T, Faros E, Nicolaides K H. Frontomaxillary facial angle in fetuses with trisomy 13 at 11+0 to 13+6 weeks. Ultrasound Obstet Gynecol 2007 30 819-823 (Pubitemid 350205401)
71. Faro C, Wegrzyn P, Benoit B, Chaoui R, Nicolaides K H. Metopic suture in fetuses with trisomy 21 at 11+0 to 13+6 weeks of gestation. Ultrasound Obstet Gynecol 2006 27 286-289 (Pubitemid 43735501)
72. Faro C, Wegrzyn P, Benoit B, Chaoui R, Nicolaides K H. Metopic suture in fetuses with holoprosencephaly at 11+0 to 13+6 weeks of gestation. Ultrasound Obstet Gynecol 2006 27 162-166 (Pubitemid 43733731)
73. Rembouskos G, Cicero S, Longo D, Vandecruys H, Nicolaides K H. Assessment of the fetal nasal bone at 1114 weeks of gestation by three-dimensional ultrasound. Ultrasound Obstet Gynecol 2004 23 232-236
74. Krantz D A., Hallahan T W., Orlandi F, Buchanan P, Larsen J W., Macri J N. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol 2000 96 207-213
75. Niemimaa M, Suonpaa M, Perheentupa A et al. Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and Northern Finland. Eur J Hum Genet 2001 9 404-408
76. Schuchter K, Hafner E, Stangi G, Metzenbauer M, Hofinger D, Philipp K. The first trimester combined test for the detection of Down syndrome pregnancies in 4939 unselected pregnancies. Prenat Diagn 2002 22 211-215
77. von Kaisenberg C S., Gasiorek-Wiens A, Bielicki M et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 1114 weeks: a German multicenter study. J Matern Fetal Neonatal Med 2002 12 89-94
78. Stenhouse E J., Crossley J A., Aitken D A., Brogan K, Cameron A D., Connor J M. First-trimester combined ultrasound screening for Down syndrome in routine clinical practice. Prenat Diagn 2004 24 774-780
79. Bach C, Torrent S, Cabrero D, Sabrià J. Cribado bioquìmico-ecogràfico de las aneuploidìas en el primer trimestre. Metodologìa y resultados. Prog Obstet Ginecol 2004 47 5-19
80. Wøjdemann K R., Shalmi A C., Christiansen M et al. Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women. Ultrasound Obstet Gynecol 2005 25 227-233
81. Hadlow N C., Hewitt B G., Dickinson J E., Jacoby P, Bower C. Community-based screening for Down's syndrome in the first trimester using ultrasound and maternal serum biochemistry. BJOG 2005 112 1561-1564
82. Nicolaides K H., Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005 25 221-226
83. Borrell A, Casals E, Fortuny A et al. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study. Prenat Diagn 2004 24 541-545
84. Cicero S, Avgidou K, Rembouskos G, Kagan K O., Nicolaides K H. Nasal bone in first-trimester screening for trisomy 21. Am J Obstet Gynecol 2006 195 109-114 (Pubitemid 43927522)
85. Weisz B, Pandya P, Chitty L, Jones P, Huttly W, Rodeck C. Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice. BJOG 2007 114 493-497
86. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006 6 31